國立虎尾科技大學 |

Ovarian Cancer Biomarkers = Mapping to Improve Outcomes /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Ovarian Cancer Biomarkers/ edited by Khalid El Bairi.
其他題名:	Mapping to Improve Outcomes /
其他作者:	El Bairi, Khalid.
面頁冊數:	XV, 229 p. 9 illus., 8 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Molecular Medicine. -
電子資源:	https://doi.org/10.1007/978-981-16-1873-4
ISBN:	9789811618734

Ovarian Cancer Biomarkers = Mapping to Improve Outcomes /
Ovarian Cancer BiomarkersMapping to Improve Outcomes /[electronic resource] :edited by Khalid El Bairi. - 1st ed. 2021. - XV, 229 p. 9 illus., 8 illus. in color.online resource.

Chapter 1. General Overview of the Origins and Pathology of Ovarian Cancer -- Chapter 2_An Introduction to the Current Management of Ovarian Cancer in the Era of Precision Oncology -- Chapter 3_The Hallmarks of Ovarian Cancer: Actionable Genetics, Targetable Pathways and Predictive Biomarkers -- Chapter 4_Genetic Alterations in Ovarian Cancer as Prognostic and Predictive Biomarkers of Therapy Response and Surgical Outcomes -- Chapter 5_The Emergence of Circulating Tumor DNA in the Management of Ovarian Cancer -- Chapter 6_Proteomic Biomarkers for Early Detection and Patients’ Stratification in Ovarian Cancer -- Chapter 7_Cutting-edge Technologies and Ovarian Cancer.

This book comprehensively summarizes the biology, etiology, and pathology of ovarian cancer and explores the role of deep molecular and cellular profiling in the advancement of precision medicine. The initial chapter discusses our current understanding of the origin, development, progression and tumorigenesis of ovarian cancer. In turn, the book highlights the development of resistance, disease occurrence, and poor prognosis that are the hallmarks of ovarian cancer. The book then reviews the role of deep molecular and cellular profiling to overcome challenges that are associated with the treatment of ovarian cancer. It explores the use of genome-wide association analysis to identify genetic variants for the evaluation of ovarian carcinoma risk and prognostic prediction. Lastly, it highlights various diagnostic and prognostic ovarian cancer biomarkers for the development of molecular-targeted therapy.

ISBN: 9789811618734

Standard No.: 10.1007/978-981-16-1873-4doiSubjects--Topical Terms:

668353
Molecular Medicine.

LC Class. No.: RC261-271

Dewey Class. No.: 614.5999

Ovarian Cancer Biomarkers = Mapping to Improve Outcomes /
LDR:02956nam a22003975i 4500 001 1055942
003 DE-He213
005 20211009075454.0
007 cr nn 008mamaa
008 220103s2021 si | s |||| 0|eng d
020 $a 9789811618734 $9 978-981-16-1873-4
024 7 $a 10.1007/978-981-16-1873-4 $2 doi
035 $a 978-981-16-1873-4
050 4 $a RC261-271
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 614.5999 $2 23
245 1 0 $a Ovarian Cancer Biomarkers $h [electronic resource] : $b Mapping to Improve Outcomes / $c edited by Khalid El Bairi.
250 $a 1st ed. 2021.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2021.
300 $a XV, 229 p. 9 illus., 8 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Chapter 1. General Overview of the Origins and Pathology of Ovarian Cancer -- Chapter 2_An Introduction to the Current Management of Ovarian Cancer in the Era of Precision Oncology -- Chapter 3_The Hallmarks of Ovarian Cancer: Actionable Genetics, Targetable Pathways and Predictive Biomarkers -- Chapter 4_Genetic Alterations in Ovarian Cancer as Prognostic and Predictive Biomarkers of Therapy Response and Surgical Outcomes -- Chapter 5_The Emergence of Circulating Tumor DNA in the Management of Ovarian Cancer -- Chapter 6_Proteomic Biomarkers for Early Detection and Patients’ Stratification in Ovarian Cancer -- Chapter 7_Cutting-edge Technologies and Ovarian Cancer.
520 $a This book comprehensively summarizes the biology, etiology, and pathology of ovarian cancer and explores the role of deep molecular and cellular profiling in the advancement of precision medicine. The initial chapter discusses our current understanding of the origin, development, progression and tumorigenesis of ovarian cancer. In turn, the book highlights the development of resistance, disease occurrence, and poor prognosis that are the hallmarks of ovarian cancer. The book then reviews the role of deep molecular and cellular profiling to overcome challenges that are associated with the treatment of ovarian cancer. It explores the use of genome-wide association analysis to identify genetic variants for the evaluation of ovarian carcinoma risk and prognostic prediction. Lastly, it highlights various diagnostic and prognostic ovarian cancer biomarkers for the development of molecular-targeted therapy.
650 2 4 $a Molecular Medicine. $3 668353
650 2 4 $a Gene Expression. $3 582691
650 1 4 $a Cancer Research. $3 668358
650 0 $a Molecular biology. $3 583443
650 0 $a Gene expression. $3 581931
650 0 $a Cancer research. $3 1253664
700 1 $a El Bairi, Khalid. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1326585
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811618727
776 0 8 $i Printed edition: $z 9789811618741
776 0 8 $i Printed edition: $z 9789811618758
856 4 0 $u https://doi.org/10.1007/978-981-16-1873-4
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)